WHO Drug Information Vol. 20, No. 1, 2006 - World Health ...

WHO Drug Information, Vol. 20, No. 1, 2006 Recommended INN: List 55valategrastumvalategrastvalatégrastvalategrast2-(diethylamino)ethyl N-(2-chloro-6-methylbenzoyl)-4-(2,6-dichlorobenzamido)-L-phenylalaninate(2S)-2-[(2-chloro-6-méthylbenzoyl)amino]-3-[4-[(2,6-dichlorobenzoyl)amino]phényl]propanoate de 2-(diéthylamino)éthyle2-(dietilamino)etil N-(2-cloro-6-metilbenzoil)-4-(2,6-diclorobenzamido)-L-fenilalaninatoC 30H 32Cl 3N 3O 4ClHNCH 3ONHClHOOON CH 3CH 3Clvalopicitabinumvalopicitabinevalopicitabinevalopicitabina3'-O-(L-valyl)-2'-C-methylcytidine4-amino-1-[3-O-[(2S)-2-amino-3-méthylbutanoyl]-2-C-méthylβ-D-ribofuranosyl]pyrimidin-2(1H)-one3'-O-(L-valil)-2'-C-metilcitidinaC 15H 24N 4O 6NH 2NH 3 CHO O NOH 3 CH NH 2O OHCH 3 Ovolociximabumvolociximabvolociximabvolociximabimmunoglobulin G4, anti-(human α5β1 integrin)(human-mouse clonep200-M heavy chain), disulfide with human-mouse clone p200-Mκ-chain, dimerimmunoglobuline G4, anti-(intégrine α5β1 humaine), dimère dudisulfure entre la chaîne lourde et la chaîne κ de l’anticorpsmonoclonal chimérique homme-souris p200-Minmunoglobulina G4, anti-(integrina α5β1 humana), dímero deldisulfuro entre la cadena pesada y la cadena κ del anticuerpomonoclonal quimérico hombre-ratón p200-MC 6434H 9942N 1706O 2040S 5255